Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 4, 2007, Pages 697-705

  Patraki, E ^a   Cardillo, Maria Rosaria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Computer assisted image analysis; Immunohistochemistry; Metalloproteinases 7; Renal cell carcinoma

Indexed keywords

MATRILYSIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STROMA; TUMOR CLASSIFICATION;

EID: 37749029732     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000405     Document Type: Article

References (39)

1. McCawley L.J. and L.M. Matrisian. 2000. Matrix metal loproteinases: multifunctional contributor to tumor progression. Mol. Med. Today 6(4):149.
2. Coussens L.M., B. Fingleton and L.M. Matrisian. 2002. Matrix metalloproteinases, inhibitors and cancer: trials and tribulations. Science 295:2387.
3. Egeblab M. and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161.
4. Zucker S. and J. Vacirca. 2004. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer and metastasis Reviews 23:101.
5. Li H.C., D.C. Cao, Y. Liu, Y.F. Hou, J. Wu, J.S. Lu, G.H. Di, G. Liu, F.M. Li, Z.L. Ou, C. Jie, Z.Z. Shen and Z.M. Shao. 2004. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Research and Treatment 88:75.
6. Sood A.K., M.S. Fletcher, J.E. Coffin, M.Yang, E.A. Seftor, L.M. Gruman, D.M. Gershenson and M.J.C. Hendrix. 2004. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J. Obstet. Gynaec. 190:899.
7. Cardillo M.R., F. Di Silverio and V. Gentile. 2006. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer. Anticancer Research 26(2A):973.
8. Hagemann T., B. Gunawan, M. Schulz, L. Fuzebi, and C. Binder. 2001. mRNA expression of matrix metalloproteinases and their inhibitors differs in subtypes of renal cell carcinomas. European J. Cancer 37:1839.
9. Kallakury B.V.S., S. Karikehalli, A. Haholu, E. Christine, C.E. Sheehan, N. Azumi and J.S. Ross. 2001. Increased expression of matrix metalloproteinase 2 and 9 and tissue inhibitors of metalloproteinases-1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin. Cancer Research 7:3113.
10. Abdel-Wahed M.M., N.Y. Asaad and M. Aleskandarany. 2004. Expression of matrix metalloproteinase-2 in renal cell carcinoma. J. of the Egyptian Nat. Cancer Inst. 16(3):168.
11. Wilson C.L. and L.M. Matrisian. 1996. Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions. Int. J. Biochem. Cell Biol. 28:123.
12. Andreasen P.A., L. Kjoller, L. Christensen and M.I. Duffy. 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72:1.
13. Mylona E., A. Kapranou, J. Mavrommatis, S. Markaki, A. Keramopoulos and L. Nakopoulou. 2005. The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer. APMIS 113:246.
14. Sillanpaa S.M., M.A. Anttila, K.A. Voutilainen, K.M. Ropponen, R.K. Sironen, S.V. Saarikoski and V.M. Kosma. 2006. Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to β-catenin expression. Int. J. Cancer 119:1792.
15. Aihara R., E. Mochiki, Y. Kamiyama, T. Ohno, T. Asao and H. Kuwano. 2006. Matrilysin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach. J. of Surgical Oncology 93:491.
16. Lee K.H. S.J. Shin, K.O. Kim, M.K. Kim, M.S. Hyun, T.N. Kim, B.I. Jang, S.W. Kim, S.K. Song, H.S. Kim, S.H. Bae and H.M. Ryoo. 2006. Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol. Rep. 16(4):823.
17. Lu Z., Y. Wang, Q. Zhang, X. Zang, S. Wang, H. Xie, Y. Li, B. Jiao and J. Zhang. 2006. Association between the functional polymorphism in the matrix metalloproteinase-7 and susceptibility to adult astrocytoma. Brain Research 1118:6.
18. Li M., H. Yamamoto, Y. Adachi, Y. Maruyama and Y. Shinomura. 2006. Role of matrix metalloproteinase-7 (matrylisin-1) in human cancer and angiogenesis. Exp. Biol. Med. 231:20.
19. Impola U., V.J. Uitto, J. Hietanen, L. Hakkinen, L. Zhang, H. Larjava, K. Isaka and U. Saarialho-Kere. 2004. Differential expression of matrilysin-I (MMP-7), 92kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J. Pathol. 202:14.
20. Ouyang X.S., X. Wang, D.T.W. Lee, S.W. Tsao and Y.C. Wong. 2001. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in Noble rat. Carcinogenesis 22(6):965.
21. Miyamoto S., K. Yano, S. Sugimoto, G. Ishii, T. Hasebe, Y. Endoh, K. Kodama, M. Goya, T. Chiba and A. Ochiai. 2004. Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res. 64:665.
22. Wang F.-Q., J. So, S. Reierstad and D.A. Fishman. 2005. Matrilysin (MMP-7) promotes invasion of ovarian cancer by activation of progelatinase. Int. J. Cancer 114(1):19.
23. Tanioka Y., T. Yoshida, T. Yagawa, Y. Saiki, S. Takeo, T. Harada, T. Okazawa, H. Yanai and K. Okita. 2003. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br. J. Cancer 89:2116.
24. Saiton Y., H. Yanai, S. Higaki, H. Nohara, T. Yoshida and K. Okita. 2004. Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer. Gastrointest. Endosc. 59(3):385.
25. Kiton T., H. Yanai, Y. Saitoh, Y. Nakamura, Y. Matsubara, H. Kitoh, T. Yoshida and K. Okita. 2004. Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer. J. Gastroenterol. 39:434.
26. Shiomi T. and Y. Okada. 2003. MT1-MMP and MMP-7 in invasion and metastasis of human cancer. Cancer Metastasis Rev. 22:145.
27. Wielockx B., C. Libert and C. Wilson. 2004. Matrilysin (matrix metalloproteinase-7): a new promoting drug target in cancer and inflammation?. Cytokine Growth Factor Rev. 15:111.
28. Surendran K., T.C. Simon, H. Liapis and J.K. McGuire. 2004. Matrilysin (MMP-7) expression in renal tubular damage: Association with Wnt4. Kidney Int. 65:2212.
29. Sumi T., T. Nakatani, H. Yoshida, Y. Hyun, T. Yasui, Y. Matsumoto, F. Nakagawa, K. Sugimura, H. Kawashima and O. Ishlkn. 2003. Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma. Oncol. Rep. 10(3):567.
30. American Joint Committee on Cancer. Cancer Staging Manual 6th ed. 2002, Lippincott-Raven, Philadelphia, p. 1.
31. Eble J.N., G. Sauter, J.I. Epstein and I.A. Sesterhenn. 2004. World Health Organization (WHO) classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. Lyons: IARC Press.
32. Fuhrmann S.A., L.C. Lasky and C. Limas. 1982. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 6:655.
33. Ouyang X.S., D.T.W. Lee, S.W. Tsao and Y.C. Wong. 2001. Up-regulation of TRPM-7, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the noble rat. Carcinogenesis 22(6):965.
34. Cardillo M.R. and F. Ippoliti. 2006. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis. Anticancer Research 26:3409.
35. Tuszynski J.A. 2001. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 7:14.
36. Heppner K.J., L.M. Matrisian, R.A. Jensen and W.H. Rodgers. 1996. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathology 149:273.
37. Leinonen T., R. Pirinen, J. Bohm, R. Johansson, K. Ropponen and V.M. Kosma. 2006. Expression of matrix metalloproteinase 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin, and prognosis. Lung Cancer 51 (3):313.
38. Ajisaka H., Y. Yonemura and K. Miwa. 2004. Correlation of lymph-node metastases and expression of matrix metalloprotreinase-7 in patients with gastric cancer. Hepato-Gastroenterology 51:900.
39. Kren L., V.N. Goncharuk, Z. Krenova, D. Stratil, M. Hermanova, J. Skrickova, C.E. Sheehan and J.S. Ross. 2006. Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies. Cesk Patol. 42(1):16.